Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.

Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.

Chronic pelvic pain (CPP) affects 2.1-24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial in two UK centres to inform the planning of a future multice...

Full description

Bibliographic Details
Main Authors: Steff C Lewis, Siladitya Bhattacharya, Olivia Wu, Katy Vincent, Stuart A Jack, Hilary O D Critchley, Maureen A Porter, Denise Cranley, John A Wilson, Andrew W Horne
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0153037

Internet

https://doi.org/10.1371/journal.pone.0153037

Similar Items